Inventor · disambiguated record
George Jackowski
Also filed as: JACKOWSKI GEORGE
73 granted patents·73 pending applications·1,512 citations·filing 1991–2021
99Inventor score
Files withJACKOWSKI GEORGE41SYN X PHARMA INC29NANOGEN INC12SPECTRAL DIAGNOSTICS INC8PIVOTAL THERAPEUTICS INC6
Top patents by PatentIndex Score
146 records- 0197US5747274AMethod and device for diagnosing and distinguishing chest pain in early onset thereofSPECTRAL DIAGNOSTICS INC·Filed 1996·Granted May 5, 1998·195 cites·25 claims
- 0296US6890763B2Biopolymer marker indicative of disease state having a molecular weight of 1350 daltonsSYN X PHARMA INC·Filed 2001·Granted May 10, 2005·79 cites·6 claims
- 0395US5290678ADiagnostic kit for diagnosing and distinguishing chest pain in early onset thereofSPECTRAL DIAGNOSTICS INC·Filed 1991·Granted Mar 1, 1994·156 cites·2 claims
- 0494US7374950B2Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patientsPRINCETON BIOMEDITECH CORP·Filed 2006·Granted May 20, 2008·26 cites·24 claims
- 0594USRE39816EConjunctive analysis of biological marker expression for predicting cardiac mortalityNANOGEN INC·Filed 2005·Granted Sep 4, 2007·30 cites·22 claims
- 0694US6461828B1Conjunctive analysis of biological marker expression for diagnosing organ failureSYN X PHARMA·Filed 2001·Granted Oct 8, 2002·86 cites·5 claims
- 0794US6235489B1Method for diagnosing and distinguishing stroke and diagnostic devices for use thereinSYN X PHARMA·Filed 2000·Granted May 22, 2001·67 cites·19 claims
- 0894US5710008AMethod and device for diagnosing and distinguishing chest pain in early onset thereofSPECTRAL DIAGNOSTICS INC·Filed 1996·Granted Jan 20, 1998·134 cites·34 claims
- 0994US5604105AMethod and device for diagnosing and distinguishing chest pain in early onset thereofSPECTRAL DIAGNOSTICS INC·Filed 1995·Granted Feb 18, 1997·152 cites·23 claims
- 1090US7527939B2Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNPNANOGEN INC·Filed 2006·Granted May 5, 2009·37 cites·4 claims
- 1188US7329501B2Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistanceNANOGEN INC·Filed 2006·Granted Feb 12, 2008·7 cites·10 claims
- 1288US6780606B1Method for diagnosing and distinguishing stroke and diagnostic devices for use thereinSYN X PHARMA·Filed 2000·Granted Aug 24, 2004·28 cites·30 claims
- 1387US5744358AMethod and device for diagnosing and distinguishing chest pain in early onset thereofSPECTRAL DIAGNOSTICS INC·Filed 1996·Granted Apr 28, 1998·77 cites·13 claims
- 1486US6451547B1Process for differential diagnosis of Alzheimer's dementia and device thereforSYN X PHARMA INC·Filed 2001·Granted Sep 17, 2002·24 cites·13 claims
- 1584US7015004B2Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistanceSYN X PHARMA INC·Filed 2001·Granted Mar 21, 2006·6 cites·9 claims
- 1684US6602855B2Biopolymer marker indicative of disease state having a molecular weight of 1449 daltonsSYN X PHARMA INC·Filed 2001·Granted Aug 5, 2003·26 cites·9 claims
- 1782US7179606B2IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's diseaseSYN X PHARMA INC·Filed 2001·Granted Feb 20, 2007·23 cites·9 claims
- 1882US6620786B2Biopolymer marker indicative of disease state having molecular weight of 2937 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 16, 2003·19 cites·9 claims
- 1981US6627606B2Biopolymer marker indicative of disease state having a molecular weight of 1465 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 30, 2003·18 cites·9 claims
- 2081US6617308B2Biopolymer marker indicative of disease state having a molecular weight of 1865 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 9, 2003·18 cites·9 claims
- 2179US6677303B2Biopolymer marker indicative of disease state having a molecular weight of 1097 daltonsSYN X PHARMA·Filed 2001·Granted Jan 13, 2004·16 cites·9 claims
- 2279US6620787B2Biopolymer marker indicative of disease state having a molecular weight of 2267 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 16, 2003·16 cites·9 claims
- 2378US9119826B2Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levelsJACKOWSKI GEORGE·Filed 2012·Granted Sep 1, 2015·2 cites·10 claims
- 2478US6703366B2Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltonsFiled 2001·Granted Mar 9, 2004·15 cites·9 claims
- 2577US11016106B2Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNPNEXUS DX INC·Filed 2016·Granted May 25, 2021·1 cites·20 claims
- 2675US5573957AMonoclonal antibody to human cardiac myoglobinSPECTRAL DIAGNOSTICS INC·Filed 1994·Granted Nov 12, 1996·44 cites·4 claims
- 2774US10912326B2Nanoformulations containing encapsulted omega-3 fatty acidsMACSWEENEY RACHELLE·Filed 2019·Granted Feb 9, 2021·1 cites·8 claims
- 2874US7314717B2Biopolymer marker indicative of disease state having a molecular weight of 1562 daltonsNANOGEN INC·Filed 2001·Granted Jan 1, 2008·10 cites·9 claims
- 2974US7109023B2Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patientsPRINCETON BIOMEDITECH CORP·Filed 2002·Granted Sep 19, 2006·12 cites·7 claims
- 3074US6627608B2Biopolymer marker indicative of disease state having a molecular weight of 1206 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 30, 2003·15 cites·9 claims
- 3174US6593298B2Biopolymer marker indicative of disease state having a molecular weight of 1690 daltonsSYN X PHARMA INC·Filed 2001·Granted Jul 15, 2003·16 cites·9 claims
- 3273US8715648B2Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabeticsJACKOWSKI GEORGE·Filed 2012·Granted May 6, 2014·3 cites·37 claims
- 3373US7135297B2Protein biopolymer markers indicative of insulin resistanceNANOGEN INC·Filed 2001·Granted Nov 14, 2006·8 cites·9 claims
- 3472US7955811B2Method for diagnosing and distinguishing stroke and diagnostic devices for use thereinNEXUS DX INC·Filed 2010·Granted Jun 7, 2011·1 cites·20 claims
- 3572US6756476B2Biopolymer marker indicative of disease state having a molecular weight of 2021 daltonsSYN X PHARMA INC·Filed 2001·Granted Jun 29, 2004·14 cites·9 claims
- 3671US7135329B2Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patientsPRINCETON BIOMEDITECH CORP·Filed 2003·Granted Nov 14, 2006·8 cites·9 claims
- 3771US6599877B2Biopolymer marker indicative of disease state having a molecular weight of 1020 daltonsSYN X PHARMA INC·Filed 2001·Granted Jul 29, 2003·13 cites·9 claims
- 3870US9371382B2Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNPDAVEY MICHELLE·Filed 2011·Granted Jun 21, 2016·2 cites·13 claims
- 3969US7655424B2Method for diagnosing and distinguishing stroke and diagnostic devices for use thereinNANOGEN INC·Filed 2004·Granted Feb 2, 2010·5 cites·12 claims
- 4069US7094549B2Fibronectin biopolymer marker indicative of insulin resistanceSYN X PHARMA INC·Filed 2001·Granted Aug 22, 2006·2 cites·9 claims
- 4169US7052849B2Protein biopolymer markers predictive of insulin resistanceSYN X PHARMA INC·Filed 2001·Granted May 30, 2006·7 cites·9 claims
- 4269US6627607B2Biopolymer marker indicative of disease state having a molecular weight of 1845 daltonsSYN X PHARMA INC·Filed 2001·Granted Sep 30, 2003·12 cites·9 claims
- 4369US2022099687A1Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnpNEXUS DX INC·Filed 2021·Application pending·0 cites
- 4468US7070945B2Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairmentSYN X PHARMA INC·Filed 2002·Granted Jul 4, 2006·7 cites·8 claims
- 4567US7294688B2Biopolymer marker indicative of disease state having a molecular weight of 1348 daltonsNANOGEN INC·Filed 2001·Granted Nov 13, 2007·5 cites·1 claims
- 4666US7074576B2Protein biopolymer markers indicative of alzheimer's diseaseSYN X PHARMA INC·Filed 2001·Granted Jul 11, 2006·1 cites·9 claims
- 4766US5702905AMonoclonal antibody to human ventricular myosin light chainsSPECTRAL DIAGNOSTICS·Filed 1994·Granted Dec 30, 1997·23 cites·3 claims
- 4865US7132244B2Betaine/GABA transport protein biopolymer marker indicative of insulin resistanceSYN X PHARMA INC·Filed 2001·Granted Nov 7, 2006·8 cites·9 claims
- 4964US7125726B2Method and kit for diagnosing myocardial infarctionARTEMIS PROTEOMICS LTD·Filed 2005·Granted Oct 24, 2006·1 cites·5 claims
- 5064US7101680B2Method for detecting the presence of monomeric brain associated human glutamine synthetaseSYN X PHARMA INC·Filed 2001·Granted Sep 5, 2006·4 cites·3 claims
Showing the top 50 of 146 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →